United States· US:50090-3482_03e8f7a3-552c-4b8e-94df-8668108baeea
FARXIGA
A medicinal product containing dapagliflozin propanediol, registered in United States by A-S Medication Solutions.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DAPAGLIFLOZIN PROPANEDIOL
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1150090-3482-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dapagliflozin propanediol in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDAGETIAPharmaPath S.A., Agia Varvara
- FinlandDapagliflozin KrkaKRKA d.d. Novo mesto
- BelgiumDapagliflozin EG 5 mgEG
- IrelandDapagliflozin Clonmel 5 mg film-coated tabletsClonmel Healthcare Ltd
- GermanyDapagliflozin CiplaCipla Europe Nv
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Austria · Dapagliflozin Denk
- Germany · Dapagliflozin Cipla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fbc8dfef-393e-4d5d-8c92-3fa55e456469 GET /v1/drugs/fbc8dfef-393e-4d5d-8c92-3fa55e456469?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "DAPAGLIFLOZIN PROPANEDIOL",
"productndc": "50090-3482",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA202293",
"marketing_category": "NDA"
}See everything about dapagliflozin propanediol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.